Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6802871 | Neurobiology of Aging | 2018 | 11 Pages |
Abstract
Oligodendrocytes are essential for structural and trophic support of motor axons. Their impairment has been implicated in amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder of motor neurons. Oligodendrocyte progenitor cells fail to differentiate into mature oligodendrocytes and thereby jeopardize the health of motor neurons. Here, we report that oligodendrocytic ablation of inhibitor of DNA binding 2 (Id2) or Notch receptor 1 (Notch1), 2 negative master modulators of oligodendrocyte differentiation, fails to alleviate oligodendrocyte dysfunction or alter disease outcome in a murine model of ALS. Our data suggest that these inhibitors are not suitable targets for intervention in ALS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Caroline Eykens, Annelies Nonneman, Cathy Jensen, Antonio Iavarone, Philip Van Damme, Ludo Van Den Bosch, Wim Robberecht,